English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: To develop and implement an online Artificial Neural Network (ANN) that provides the probability of a subject having mild cognitive impairment (MCI) or Alzheimer’s disease (AD). Method: Different ANNs were trained using a sample of 350 controls (CONT), 75 MCI and 93 AD subjects. The ANN structure chosen was the following: (1) an input layer of 33 cognitive variables from the Neuronorma battery plus two sociodemographic variables, age and education. This layer was reduced to a 15 features input vector using Multiple Discriminant Analysis method, (2) one hidden layer with 8 neurons, and (3) three output neurons corresponding to the 3 expected cognitive states. This ANN was defined in a previous study [28]. The ANN was implemented on the web site www.test-barcelona.com (Test Barcelona Workstation) [9]. Results: When comparing CONT, MCI and AD participants, the best ANN correctly classifies up to 94,87% of the study participants. Conclusions: The online implemented ANN, delivers the probabilities (%) of belonging to the CONT, MCI and AD groups of a subject assessed using the 35 characteristics (variables) of the Neuronorma profile. This tool is a good complement for the interpretation of cognitive profiles. This technology improves clinical decision making. Keywords: Artificial Neural Network, Probability, Alzheimer disease, Test Barcelona Workstation.

kne life sciences

Implementation of an Artificial Neural Network on the Test Barcelona Workstation As a Predictive Model for the Classification of Normal, Mild Cognitive Impairment and Alzheimer’s Disease Subjects Using the Neuronorma Battery